During the past decade, Michigan Cancer Specialists conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 18 clinical trials were completed, i.e. on average, 56.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 18 clinical trials were completed. i.e. 1800% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Michigan Cancer Specialists" #1 sponsor was "National Cancer Institute (NCI)" with 15 trials, followed by "Alliance for Clinical Trials in Oncology" with 10 trials sponsored, "SWOG Cancer Research Network" with 10 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored and "NRG Oncology" with 4 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Michigan Cancer Specialists" #1 collaborator was "National Cancer Institute (NCI)" with 25 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Division of Cancer Control" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Michigan Cancer Specialists" are "Recurrent Squamous Cell Lung Carcinoma" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (6 trials), "Stage IIIA Breast Cancer" (5 trials), "Stage II Breast Cancer" (4 trials) and "Breast Carcinoma" (3 trials). Many other conditions were trialed in "Michigan Cancer Specialists" in a lesser frequency.

Most popular intervention types in "Michigan Cancer Specialists" are "Other" (32 trials), "Drug" (31 trials), "Biological" (12 trials), "Procedure" (11 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (20 trials), "Quality-of-Life Assessment" (10 trials), "Biospecimen Collection" (5 trials), "Computed Tomography" (5 trials) and "Nivolumab" (5 trials). Other intervention names were less common.

The vast majority of trials in "Michigan Cancer Specialists" are 36 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Michigan Cancer Specialists". undefined are not yet recruiting, 3 are recruiting, 26 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Michigan Cancer Specialists, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Michigan Cancer Specialists, 0 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".